用于心脏代谢疾病的分子生物标志物：年轻人的风险评估。
Molecular Biomarkers for Cardiometabolic Disease: Risk Assessment in Young Individuals.
机构信息
Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School.
出版信息
Circ Res. 2023 Jun 9;132(12):1663-1673. doi: 10.1161/CIRCRESAHA.123.322000. Epub 2023 Jun 8.
Abstract
Cardiometabolic diseases, including cardiovascular disease and diabetes, are major causes of morbidity and mortality worldwide. Despite progress in prevention and treatment, recent trends show a stalling in the reduction of cardiovascular disease morbidity and mortality, paralleled by increasing rates of cardiometabolic disease risk factors in young adults, underscoring the importance of risk assessments in this population. This review highlights the evidence for molecular biomarkers for early risk assessment in young individuals. We examine the utility of traditional biomarkers in young individuals and discuss novel, nontraditional biomarkers specific to pathways contributing to early cardiometabolic disease risk. Additionally, we explore emerging omic technologies and analytical approaches that could enhance risk assessment for cardiometabolic disease.
摘要
心血管疾病和糖尿病等心脏代谢疾病是全球发病率和死亡率的主要原因。尽管在预防和治疗方面取得了进展，但最近的趋势显示，心血管疾病发病率和死亡率的下降趋势停滞不前，与此同时，年轻人的心脏代谢疾病风险因素的发生率却在上升，这突显出对这一年龄段人群进行风险评估的重要性。本综述重点介绍了用于年轻人早期风险评估的分子生物标志物的证据。我们检查了传统生物标志物在年轻人中的应用，并讨论了特定于导致早期心脏代谢疾病风险的途径的新型非传统生物标志物。此外，我们还探讨了新兴的组学技术和分析方法，这些方法可能会增强心脏代谢疾病的风险评估。
相似文献
1
Molecular Biomarkers for Cardiometabolic Disease: Risk Assessment in Young Individuals.用于心脏代谢疾病的分子生物标志物：年轻人的风险评估。
Circ Res. 2023 Jun 9;132(12):1663-1673. doi: 10.1161/CIRCRESAHA.123.322000. Epub 2023 Jun 8.
2
Omics and Cardiometabolic Disease Risk Prediction.组学与心血管疾病风险预测。
Annu Rev Med. 2020 Jan 27;71:163-175. doi: 10.1146/annurev-med-042418-010924.
3
Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.基于性别的心血管代谢风险评估在少数族裔和非少数族裔男性中的应用——评估非传统心血管风险决定因素的证据。
Int J Clin Pract. 2011 Feb;65(2):134-47. doi: 10.1111/j.1742-1241.2010.02564.x. Epub 2010 Dec 29.
4
Plasma vitamin D and biomarkers of cardiometabolic disease risk in adult Canadians, 2007-2009.2007-2009 年加拿大成年人血浆维生素 D 与心血管代谢疾病风险生物标志物。
Prev Chronic Dis. 2013 Jun 6;10:E91. doi: 10.5888/pcd10.120230.
5
Does autonomic nervous system dysfunction influence cardiovascular disease risk in young adults with intellectual disability?自主神经系统功能障碍是否会影响年轻智障成年人的心血管疾病风险？
Am J Physiol Heart Circ Physiol. 2021 Feb 1;320(2):H891-H900. doi: 10.1152/ajpheart.00807.2020. Epub 2020 Dec 31.
6
Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.运动训练对心肺适能及心脏代谢健康生物标志物的影响：随机对照试验的系统评价与荟萃分析
J Am Heart Assoc. 2015 Jun 26;4(7):e002014. doi: 10.1161/JAHA.115.002014.
7
Linking of metabolomic biomarkers with cardiometabolic health in Chinese population.中国人群代谢组学生物标志物与心脏代谢健康的关联。
J Diabetes. 2019 Apr;11(4):280-291. doi: 10.1111/1753-0407.12858. Epub 2018 Oct 30.
8
Plasma 25-hydroxyvitamin D, hormonal contraceptive use, and cardiometabolic disease risk in an ethnically diverse population of young adults.不同种族年轻人群体中血浆25-羟基维生素D、激素避孕药使用情况与心血管代谢疾病风险
J Am Coll Nutr. 2013;32(5):296-306. doi: 10.1080/07315724.2013.826112.
9
Next Generation, Modifiable Cardiometabolic Biomarkers: Mitochondrial Adaptation and Metabolic Resilience: A Scientific Statement From the American Heart Association.下一代可改变的心脏代谢生物标志物：线粒体适应和代谢弹性：美国心脏协会的科学声明。
Circulation. 2023 Nov 28;148(22):1827-1845. doi: 10.1161/CIR.0000000000001185. Epub 2023 Oct 30.
10
Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile.血压正常高值人群：不良心血管代谢风险特征的标志物。
Hypertens Res. 2010 Sep;33(9):905-10. doi: 10.1038/hr.2010.91. Epub 2010 Jun 10.
引用本文的文献
1
Joint and Temporal Relationships of Systemic Inflammation and Atherogenic Dyslipidemia with Risk of Cardiometabolic Disease: A Longitudinal Cohort Study.全身炎症和致动脉粥样硬化性血脂异常与心脏代谢疾病风险的关节和时间关系：一项纵向队列研究。
J Inflamm Res. 2025 Aug 27;18:11841-11852. doi: 10.2147/JIR.S527515. eCollection 2025.
2
Cardiometabolic risk assessment by anthropometric and biochemical indices in mexican population.墨西哥人群中通过人体测量和生化指标进行的心血管代谢风险评估
Front Endocrinol (Lausanne). 2025 Jul 14;16:1588469. doi: 10.3389/fendo.2025.1588469. eCollection 2025.
3
Dietary Structure and Cardiometabolic Risk Factors: A Comparative Analysis of Lingnan and Central Plains Regions in China Based on China Nutrition and Health Surveillance 2015-2017.饮食结构与心血管代谢风险因素：基于2015 - 2017年中国营养与健康监测的中国岭南与中原地区比较分析
Nutrients. 2025 Jun 30;17(13):2173. doi: 10.3390/nu17132173.
4
A Bibliometric and Visualization Analysis of Metabolic Reprogramming in Cardiovascular Diseases: Trends, Key Contributors, and Future Directions from 2000 to 2024.心血管疾病中代谢重编程的文献计量与可视化分析：2000年至2024年的趋势、主要贡献者及未来方向
Curr Cardiol Rev. 2025;21(4):e1573403X371021. doi: 10.2174/011573403X371021250109064231.
5
Comparison of triglyceride-glucose related indices in prediction of cardiometabolic disease incidence among US midlife women.甘油三酯-葡萄糖相关指标在美国中年女性心血管代谢疾病发病预测中的比较
Sci Rep. 2025 Jun 3;15(1):19359. doi: 10.1038/s41598-025-03333-9.
6
The impact of dietary interventions on cardiometabolic health.饮食干预对心脏代谢健康的影响。
Cardiovasc Diabetol. 2025 May 31;24(1):234. doi: 10.1186/s12933-025-02766-w.
7
Understanding the Role of Adipokines in Cardiometabolic Dysfunction: A Review of Current Knowledge.了解脂肪因子在心脏代谢功能障碍中的作用：当前知识综述
Biomolecules. 2025 Apr 23;15(5):612. doi: 10.3390/biom15050612.
8
Multiorgan Imaging for Interorgan Crosstalk in Cardiometabolic Diseases.用于心脏代谢疾病中器官间相互作用的多器官成像
Circ Res. 2025 May 23;136(11):1454-1475. doi: 10.1161/CIRCRESAHA.125.325517. Epub 2025 May 22.
9
The comprehensive effects of high-sensitivity C-reactive protein and triglyceride glucose index on cardiometabolic multimorbidity.高敏C反应蛋白和甘油三酯葡萄糖指数对心脏代谢多种共病的综合影响。
Front Endocrinol (Lausanne). 2025 Apr 1;16:1511319. doi: 10.3389/fendo.2025.1511319. eCollection 2025.
10
Cardiac Repair and Regeneration via Advanced Technology: Narrative Literature Review.通过先进技术实现心脏修复与再生：叙述性文献综述
JMIR Biomed Eng. 2025 Mar 8;10:e65366. doi: 10.2196/65366.
本文引用的文献
1
Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020.美国 2009 年至 2020 年 20 至 44 岁成年人心血管危险因素流行率、治疗和控制情况。
JAMA. 2023 Mar 21;329(11):899-909. doi: 10.1001/jama.2023.2307.
2
Association of Rare Protein-Truncating DNA Variants in APOB or PCSK9 With Low-density Lipoprotein Cholesterol Level and Risk of Coronary Heart Disease.载脂蛋白 B 或前蛋白转化酶枯草溶菌素 9 中罕见蛋白截断 DNA 变异与低密度脂蛋白胆固醇水平及冠心病风险的关联。
JAMA Cardiol. 2023 Mar 1;8(3):258-267. doi: 10.1001/jamacardio.2022.5271.
3
Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease.载脂蛋白蛋白质组学与冠心病残余脂质相关风险
Circ Res. 2023 Feb 17;132(4):452-464. doi: 10.1161/CIRCRESAHA.122.321690. Epub 2023 Jan 24.
4
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention.冠心病多基因风险评分在一级预防中的预测效用。
JAMA Cardiol. 2023 Feb 1;8(2):130-137. doi: 10.1001/jamacardio.2022.4466.
5
Predictive Utility of a Validated Polygenic Risk Score for Long-Term Risk of Coronary Heart Disease in Young and Middle-Aged Adults.一种经验证的多基因风险评分对中青年长期冠心病风险的预测效用。
Circulation. 2022 Aug 23;146(8):587-596. doi: 10.1161/CIRCULATIONAHA.121.058426. Epub 2022 Jul 26.
6
Association of adolescent lipoprotein subclass profile with carotid intima-media thickness and comparison to adults: Prospective population-based cohort studies.青少年脂蛋白亚类谱与颈动脉内膜中层厚度的关联及与成年人的比较：前瞻性基于人群的队列研究。
Atherosclerosis. 2022 Jan;341:34-42. doi: 10.1016/j.atherosclerosis.2021.12.007. Epub 2021 Dec 16.
7
Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study.代谢组学分析杰克逊心脏研究中非裔美国人队列的冠心病
JAMA Cardiol. 2022 Feb 1;7(2):184-194. doi: 10.1001/jamacardio.2021.4925.
8
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events.青年期和中年时期累积低密度脂蛋白胆固醇暴露与心血管事件风险的关系。
JAMA Cardiol. 2021 Dec 1;6(12):1406-1413. doi: 10.1001/jamacardio.2021.3508.
9
Obesity in US children increased at an unprecedented rate during the pandemic.疫情期间，美国儿童肥胖率以前所未有的速度上升。
BMJ. 2021 Sep 21;374:n2332. doi: 10.1136/bmj.n2332.
10
Polygenic Risk Score to Identify Subclinical Coronary Heart Disease Risk in Young Adults.多基因风险评分识别青年亚临床冠心病风险。
Circ Genom Precis Med. 2021 Oct;14(5):e003341. doi: 10.1161/CIRCGEN.121.003341. Epub 2021 Aug 31.
Zotero 插件